Monday, August 19, 2013

Recent Market Report: Global Industry Psychotherapeutic Drugs Market Growth 2013 - 2019

Psychotherapeutic drugs market is comprised of drugs which are used to treat mental illnesses such as confused thinking, extreme mood swings, long lasting depression, social withdrawal and suicidal thought. Commonly found mental disorders are schizophrenia, bipolar disorder, anxiety and depression. Schizophrenia is a mental disease associated with hearing voices, unorganized speech and broken thoughts. Depression is a common disorder characterized by lack of confidence, pleasure and interest.

The global Psychotherapeutic Drugs Market is segmented on the basis of various therapeutic classes used to treat mental illness such as antipsychotics (chlorpromazine, haloperidol), antidepressants (amitriptyline, clomipramine), antimaniacs (lithium, carbamazepine) and anxiety drugs (lorazepam, alprazolam). Antipsychotic is one of the fastest growing segments owing to increasing incidences of mental disorders such as schizophrenia and bipolar disorder. Atypical antipsychotics are the most preferred antipsychotics because they are more efficacious than first generation antipsychotics. Top selling antipsychotic drugs are Abilify, Seroquel, Risperdal and Zyprexa.

The global psychotherapeutic drugs market is growing worldwide due to high prevalence of emotional and mental diseases. According to WHO report approximately 350 million people are suffering from depression and around 24 million people are affected by schizophrenia around the world as of today. Patent expiration of top psychotic drugs Prozac, Geodon and Zyprexia has opened way for generic manufacturers and it is expected that in coming years generic segment will rise dramatically and will give rise price competition in the psychotherapeutic drugs market. 

America has been the largest market accounting for more than 40% of the total psychotherapeutic drugs market owing to high incidences of schizophrenia and depression among baby boomers. It is predicted that the market will witness rapid growth in Asia-Pacific under the influence of changing life style, disease awareness and growing aging population.

The key players operating in this market are Eli Lilly, Bristol-Meyer Squibb, GlaxoSmithKline, Pfizer, Astrazeneca, Astellas Pharma Inc., Wyeth and Johnson & Johnson.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World 

To Buy The Copy of This Report Visit :

This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 


M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

No comments:

Post a Comment